This analysis indicated variable modulation of proline hydroxylation in type I and type III collagen chains, including a substantial cluster of hydroxyproline-containing peptides derived from COL1A1 that were up-regulated in tumour ECM (Figure 3D; Supplementary Figures 3C, D). The gene discussed is COL1A1; the disease is neoplasm.